These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 18186114

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of overt extraocular retinoblastoma.
    Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.
    Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 25. Cholesterosis following chemoreduction for advanced retinoblastoma.
    Gombos DS, Howes E, O'Brien JM.
    Arch Ophthalmol; 2000 Mar; 118(3):440-1. PubMed ID: 10721978
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL.
    J Clin Oncol; 2011 Mar 01; 29(7):845-51. PubMed ID: 21282531
    [Abstract] [Full Text] [Related]

  • 28. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH.
    Br J Ophthalmol; 2004 Aug 01; 88(8):1069-73. PubMed ID: 15258027
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Retinoblastoma--a clinico-pathological study in Ilorin, Nigeria.
    Owoeye JF, Afolayan EA, Ademola-Popoola DS.
    Afr J Health Sci; 2006 Aug 01; 13(1-2):117-23. PubMed ID: 17348751
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.
    Sastre X, Chantada GL, Doz F, Wilson MW, de Davila MT, Rodríguez-Galindo C, Chintagumpala M, Chévez-Barrios P, International Retinoblastoma Staging Working Group.
    Arch Pathol Lab Med; 2009 Aug 01; 133(8):1199-202. PubMed ID: 19653709
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma.
    Bellaton E, Bertozzi AI, Behar C, Chastagner P, Brisse H, Sainte-Rose C, Doz F, Desjardins L.
    Br J Ophthalmol; 2003 Mar 01; 87(3):327-9. PubMed ID: 12598448
    [Abstract] [Full Text] [Related]

  • 38. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug 01; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 39. A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma.
    Wyse E, Handa JT, Friedman AD, Pearl MS.
    Pediatr Radiol; 2016 Aug 01; 46(9):1223-33. PubMed ID: 26886915
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.